Table 3.
Characteristic | Number (%) (n = 37) |
Levodopa-Carbidopa | 36 (100.00) |
MAO-B Inhibitors | 20 (55.56) |
Dopaminergic Agonists | 15 (41.67) |
Anticholinergic Agents | 2 (5.56) |
Amantadine | 7 (19.44) |
COMT inhibitor (Entcapone) | 4/35 (11.43) |
Characteristic | Number (%) (n = 37) |
Levodopa-Carbidopa | 36 (100.00) |
MAO-B Inhibitors | 20 (55.56) |
Dopaminergic Agonists | 15 (41.67) |
Anticholinergic Agents | 2 (5.56) |
Amantadine | 7 (19.44) |
COMT inhibitor (Entcapone) | 4/35 (11.43) |